Lixte Biotechnology LIXT Stock
Lixte Biotechnology Price Chart
Lixte Biotechnology LIXT Financial and Trading Overview
Lixte Biotechnology stock price | 1.22 USD |
Previous Close | 4.97 USD |
Open | 4.97 USD |
Bid | 0 USD x 2900 |
Ask | 0 USD x 1000 |
Day's Range | 4.62 - 4.97 USD |
52 Week Range | 4.3 - 27 USD |
Volume | 19.1K USD |
Avg. Volume | 10.15K USD |
Market Cap | 7.91M USD |
Beta (5Y Monthly) | -0.34014 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.59 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
LIXT Valuation Measures
Enterprise Value | 7.69M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 13.610315 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Lixte Biotechnology Stock Price History
Beta (5Y Monthly) | -0.34014 |
52-Week Change | -35.81% |
S&P500 52-Week Change | 20.43% |
52 Week High | 27 USD |
52 Week Low | 4.3 USD |
50-Day Moving Average | 6.37 USD |
200-Day Moving Average | 6.7 USD |
LIXT Share Statistics
Avg. Volume (3 month) | 10.15K USD |
Avg. Daily Volume (10-Days) | 22.3K USD |
Shares Outstanding | 1.67M |
Float | 717.14K |
Short Ratio | 0.41 |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | 2.95K |
Short % of Float | 0.20% |
Short % of Shares Outstanding | 0.18% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -89.17% |
Return on Equity (ttm) | -159.47% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | -6023276 USD |
Diluted EPS (ttm) | -3.48 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 4.09M USD |
Total Cash Per Share (mrq) | 2.45 USD |
Total Debt (mrq) | 0 USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 17.324 |
Book Value Per Share (mrq) | 0.349 |
Cash Flow Statement
Operating Cash Flow (ttm) | -4848009 USD |
Levered Free Cash Flow (ttm) | -2598182 USD |
Profile of Lixte Biotechnology
Country | United States |
State | CA |
City | Pasadena |
Address | 680 East Colorado Boulevard |
ZIP | 91101 |
Phone | 631 830 7092 |
Website | https://lixte.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 3 |
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.
Q&A For Lixte Biotechnology Stock
What is a current LIXT stock price?
Lixte Biotechnology LIXT stock price today per share is 1.22 USD.
How to purchase Lixte Biotechnology stock?
You can buy LIXT shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lixte Biotechnology?
The stock symbol or ticker of Lixte Biotechnology is LIXT.
Which industry does the Lixte Biotechnology company belong to?
The Lixte Biotechnology industry is Biotechnology.
How many shares does Lixte Biotechnology have in circulation?
The max supply of Lixte Biotechnology shares is 2.68M.
What is Lixte Biotechnology Price to Earnings Ratio (PE Ratio)?
Lixte Biotechnology PE Ratio is now.
What was Lixte Biotechnology earnings per share over the trailing 12 months (TTM)?
Lixte Biotechnology EPS is -1.59 USD over the trailing 12 months.
Which sector does the Lixte Biotechnology company belong to?
The Lixte Biotechnology sector is Healthcare.
Lixte Biotechnology LIXT included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}